Drug Shortage Report for XARELTO

Last updated on 2021-04-07 History
Report ID 136891
Drug Identification Number 02378612
Brand name XARELTO
Common or Proper name rivaroxaban tablets
Company Name BAYER INC
Market Status MARKETED
Active Ingredient(s) RIVAROXABAN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90's
ATC code B01AF
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-04-09
Actual start date
Estimated end date 2021-04-12
Actual end date 2021-04-07
Shortage status Avoided shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-04-05 English Compare
v2 2021-04-05 French Compare
v3 2021-04-05 English Compare
v4 2021-04-05 French Compare
v5 2021-04-07 English Compare
v6 2021-04-07 French Compare